Over the last several months, many product liability lawsuits have been filed against the manufacturers of the drug Zantac. Zantac is a heartburn medication that was available in both prescription and over-the-counter versions. Recently, the FDA asked that the product be pulled from the shelves because they found it was contaminated with a cancer-causing agent.
The contamination involves NDMA. When the medication is kept at certain high temperatures, it makes the NDMA’s impact even worse. Many patients who have taken the drug have reported being diagnosed with cancer.
The drug allegedly causes several types of cancer, including bladder, prostate, kidney and thyroid cancer. One of the cases even involves an 8-year old boy who is suffering from testicular cancer. His mom had taken Zantac while she was pregnant with the child.
There are about 40 plaintiffs who have filed suit against the drug manufacturers in California. Their attorneys have requested that their cases be consolidated with a mass tort lawsuit in Florida. This way, the cases can be tried together. Sometimes this also means a higher payout and lower proof threshold for the plaintiffs.
The defendants named in the lawsuits so far include the following:
- GlaxoSmithKline, LLC
- Boehringer Ingelheim Vetmedica, Inc
- Pfizer, Inc
The main questions involved in the case include whether the drug does indeed cause cancer and whether the defendants were aware of this risk.
It wasn’t until this year that the FDA confirmed that there was a potential cancer-causing agent in the drug. It seems that the NDMA, while dangerous, becomes even more dangerous when stored above a certain temperature. In fact, the risk is so apparent, many stores decided, on their own, to stop selling the product more than six months ago.
If you’ve taken Zantac and fear it may have gotten you sick, call our office right away.